Original breve
Supervivencia a largo plazo de los fármacos biológicos anti-TNF subcutáneos administrados durante los años 2008-2012 en una cohorte de pacientes con artritis reumatoide
Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients
Noelia Alvarez Rivas, Tomas R. Vazquez Rodriguez, Jose A. Miranda Filloy, Carlos Garcia-Porrua
, Amalia Sanchez-Andrade Fernández
Autor para correspondencia
Sección de Reumatología, Hospital Universitario Lucus Augusti, Lugo, España
Leído
9191
Vecesse ha leído el artículo
2703
Total PDF
6488
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 9 | 15 |
| 2025 5 | 161 | 42 | 203 |
| 2025 4 | 125 | 31 | 156 |
| 2025 3 | 151 | 21 | 172 |
| 2025 2 | 121 | 41 | 162 |
| 2025 1 | 143 | 29 | 172 |
| 2024 12 | 100 | 29 | 129 |
| 2024 11 | 107 | 34 | 141 |
| 2024 10 | 109 | 24 | 133 |
| 2024 9 | 88 | 21 | 109 |
| 2024 8 | 106 | 26 | 132 |
| 2024 7 | 79 | 23 | 102 |
| 2024 6 | 114 | 27 | 141 |
| 2024 5 | 112 | 29 | 141 |
| 2024 4 | 93 | 28 | 121 |
| 2024 3 | 88 | 31 | 119 |
| 2024 2 | 62 | 18 | 80 |
| 2024 1 | 83 | 24 | 107 |
| 2023 12 | 60 | 28 | 88 |
| 2023 11 | 74 | 22 | 96 |
| 2023 10 | 93 | 29 | 122 |
| 2023 9 | 131 | 35 | 166 |
| 2023 8 | 51 | 12 | 63 |
| 2023 7 | 59 | 26 | 85 |
| 2023 6 | 65 | 36 | 101 |
| 2023 5 | 83 | 29 | 112 |
| 2023 4 | 72 | 17 | 89 |
| 2023 3 | 130 | 27 | 157 |
| 2023 2 | 90 | 23 | 113 |
| 2022 1 | 77 | 29 | 106 |
| 2022 12 | 103 | 31 | 134 |
| 2022 11 | 121 | 41 | 162 |
| 2022 10 | 97 | 34 | 131 |
| 2022 9 | 105 | 36 | 141 |
| 2022 8 | 103 | 69 | 172 |
| 2022 7 | 82 | 61 | 143 |
| 2022 6 | 56 | 34 | 90 |
| 2022 5 | 78 | 44 | 122 |
| 2022 4 | 68 | 47 | 115 |
| 2022 3 | 74 | 43 | 117 |
| 2022 2 | 68 | 39 | 107 |
| 2021 1 | 98 | 49 | 147 |
| 2021 12 | 68 | 38 | 106 |
| 2021 11 | 74 | 41 | 115 |
| 2021 10 | 78 | 51 | 129 |
| 2021 9 | 88 | 52 | 140 |
| 2021 8 | 72 | 29 | 101 |
| 2021 7 | 72 | 55 | 127 |
| 2021 6 | 117 | 37 | 154 |
| 2021 5 | 119 | 61 | 180 |
| 2021 4 | 237 | 76 | 313 |
| 2021 3 | 123 | 33 | 156 |
| 2021 2 | 67 | 37 | 104 |
| 2020 1 | 62 | 26 | 88 |
| 2020 12 | 74 | 26 | 100 |
| 2020 11 | 90 | 24 | 114 |
| 2020 10 | 52 | 23 | 75 |
| 2020 9 | 91 | 36 | 127 |
| 2020 8 | 110 | 26 | 136 |
| 2020 7 | 90 | 35 | 125 |
| 2020 6 | 56 | 26 | 82 |
| 2020 5 | 69 | 26 | 95 |
| 2020 4 | 59 | 26 | 85 |
| 2020 3 | 74 | 28 | 102 |
| 2020 2 | 80 | 30 | 110 |
| 2020 1 | 82 | 32 | 114 |
| 2019 12 | 84 | 27 | 111 |
| 2019 11 | 64 | 18 | 82 |
| 2019 10 | 70 | 15 | 85 |
| 2019 9 | 43 | 32 | 75 |
| 2019 8 | 34 | 43 | 77 |
| 2019 7 | 47 | 22 | 69 |
| 2019 5 | 2 | 2 | 4 |
| 2019 3 | 9 | 0 | 9 |
| 2019 2 | 5 | 4 | 9 |
| 2019 1 | 35 | 28 | 63 |
| 2018 12 | 76 | 37 | 113 |
| 2018 11 | 17 | 13 | 30 |
| 2018 10 | 10 | 8 | 18 |
| 2018 9 | 2 | 7 | 9 |
| 2018 8 | 0 | 9 | 9 |
| 2018 7 | 0 | 3 | 3 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 12 | 12 |
| 2018 3 | 0 | 17 | 17 |
| 2018 2 | 0 | 11 | 11 |
| 2018 1 | 0 | 9 | 9 |
| 2017 12 | 0 | 13 | 13 |
| 2017 11 | 0 | 13 | 13 |
| 2017 10 | 0 | 18 | 18 |
| 2017 9 | 0 | 14 | 14 |
| 2017 8 | 0 | 22 | 22 |
| 2017 7 | 0 | 26 | 26 |
| 2017 6 | 0 | 67 | 67 |
| 2017 5 | 0 | 10 | 10 |
Mostrar todo
